Sees FY24 revenue $654M-$694.5M, consensus $633.16M. Sees FY24 adjusted EBITDA $50.7M-$53.8M. “The Company’s updated guidance incorporates current operations and organic growth, diluted weighted average shares outstanding of approximately 30.7 million, and a 25.8% effective tax rate,” stated Lynette Walbom, Pennant’s Chief Financial Officer. “It anticipates continued strong operating performance through the end of the year, hospice reimbursement rate adjustments, increased interest expense, and the contributions from our joint ventures and management agreements. It excludes unannounced acquisitions, the announced purchase of Signature’s Oregon assets, start-ups, share-based compensation, acquisition-related costs, or one-time implementation and unusual items.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PNTG:
- Pennant Group Enhances Investor Relations with Presentation Update
- Pennant Completes Acquisition of Signature Healthcare at Home’s Washington and Idaho Assets
- The Pennant Group Announces New $250 Million Credit Facility
- Pennant Announces Second Quarter 2024 Earnings Release and Call
- Pennant Group price target raised to $28 from $25 at Truist